PASTIC Dspace Repository

Efficacy of mifepristone plus Shenqi Yangxue Granulesfor hysteromyoma complicated with anemia and its effect on hemoglobin, erythrocytes and hematocrit

Show simple item record

dc.contributor.author Ye, Renli
dc.contributor.author Jiang, Yan
dc.date.accessioned 2022-12-07T05:08:19Z
dc.date.available 2022-12-07T05:08:19Z
dc.date.issued 2022-05-06
dc.identifier.citation Ye, R., & Jiang, Y. (2022). Efficacy of mifepristone plus Shenqi Yangxue Granulesfor hysteromyoma complicated with anemia and its effect on hemoglobin, erythrocytes and hematocrit. Pakistan Journal of Pharmaceutical Sciences, 35(3 (Special)), 905-910. en_US
dc.identifier.issn 1011-601X
dc.identifier.uri http://142.54.178.187:9060/xmlui/handle/123456789/14808
dc.description.abstract To assess the clinical efficacy of mifepristone complicated with anemia and its effect on the hemoglobin, red blood cell, as well as hematocrit. Sixty patients with hysteromyoma complicated with anemia between December 2018 and December 2020 were recruited and assigned to receive either mifepristone (control group, n=30) or mifepristone plus Shenqi Yangxue Granules (experimental group, n=30) based on the admission order. The two groups were compared in clinical efficiency, incidence of adverse reactions, myoma volume, uterine volume, and clinical indicators. The experimental group got a notably higher total treatment efficiency than the control group (P<0.05). The experimental group obtained a remarkably lower incidence of adverse reactions and smaller myoma volume and uterine volume than the control group (P<0.05). Patients in the experimental group showed lower hemoglobin levels and higher hematocrit levels than the control group (P<0.05). Combined therapy of mifepristone plus Shenqi Yangxue Granules resulted in lower erythrocyte aggregation index, erythrocyte sedimentation rate, in patients in the study group than those receiving mifepristone alone in the control group (P<0.05). Mifepristone plus Shenqi Yangxue Granules for patients with hysteromyoma complicated with anemia mitigates the clinical symptoms of patients and reduces the incidence of adverse reactions, with a high safety profile. en_US
dc.language.iso en en_US
dc.publisher Karachi: Faculty of Pharmacy & Pharmaceutical Sciences, Karachi en_US
dc.subject Mifepristone en_US
dc.subject Shenqi Yangxue Granules en_US
dc.subject hysteromyoma with anemia en_US
dc.subject blood picture en_US
dc.title Efficacy of mifepristone plus Shenqi Yangxue Granulesfor hysteromyoma complicated with anemia and its effect on hemoglobin, erythrocytes and hematocrit en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account